HuGE Literature Finder
Records
1
-
3
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients. Investigational new drugs 2015 Feb 33 (1): 257-68. Narjoz C, Cessot A, Thomas-Schoemann A, Golmard J L, Huillard O, Boudou-Rouquette P, Behouche A, Taieb F, Durand J P, Dauphin A, Coriat R, Vidal M, Tod M, Alexandre J, Loriot M A, Goldwasser F, Blanchet |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006 Nov 1 (9): 972-8. Pillot Giancarlo A, Read William L, Hennenfent Kristin L, Marsh Sharon, Gao Feng, Viswanathan Avinash, Cummings Kristopher, McLeod Howard L, Govindan Ramaswa |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 22, 2022
- Content source: